CELSCI Corporation (CVM)

Healthcare | Biotechnology
Latest reporting period: 2025-12-31

Latest Quarter

2025-12-31

Revenue

$0.0

Net Income

-$5.5M

Operating Margin

N/A

Free Cash Flow

-$17.2B

Debt / Assets

43.3%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for CELSCI Corporation (CVM).
Income Statement (Quarterly) 2025-12-31 2025-03-31 2024-12-31 2024-09-30
Revenue 0 0 0 0
Cost of Revenue 964,422 0 0 991,580
Gross Profit -964,422 0 0 -991,580
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 727,154 0 2,463,355 1,643,157
Operating Expenses 4,404,384 0 5,898,226 5,128,824
Operating Income -5,368,806 0 -6,893,418 -6,120,404
Interest Expense 87,789 0 170,103 174,571
Income Before Tax -5,469,446 0 -7,073,062 -6,109,492
Income Tax Expense 0 0 0 -171,753
Net Income -5,469,446 0 -7,073,062 -6,109,492
Per Share
EPS -0.68 -0.08 -0.11 -0.11
EPS Diluted 0.00 0.00 0.00 0.00